These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18589161)

  • 1. Mechanisms of survival prolongation of murine cardiac allografts using the treatment of CTLA4-Ig and MR1.
    Zhu P; Chen YF; Chen XP; Li D; Cheng Q; Huang ZY; Zhang WG; Xiao ZY
    Transplant Proc; 2008 Jun; 40(5):1618-24. PubMed ID: 18589161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.
    Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP
    Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of NKG2D synergized with CTLA4-Ig in promoting long-term graft survival in murine models of cardiac transplantation.
    Li J; Zhu H; Wang S; Ye P; Liu C; Wu J; Xia J
    Transplantation; 2012 Feb; 93(4):356-63. PubMed ID: 22179404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
    Shi W; Chen M; Xie L
    Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
    J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y; Tang XD; Zhou PJ
    Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
    Stell D; Marshall H; Bradley JA; Bolton EM
    Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of corneal allografts by CTLA4-Ig.
    Gebhardt BM; Hodkin M; Varnell ED; Kaufman HE
    Cornea; 1999 May; 18(3):314-20. PubMed ID: 10336035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged cardiac allograft survival in rats systemically injected adenoviral vectors containing CTLA4Ig-gene.
    Kita Y; Li XK; Ohba M; Funeshima N; Enosawa S; Tamura A; Suzuki K; Amemiya H; Hayashi S; Kazui T; Suzuki S
    Transplantation; 1999 Sep; 68(6):758-66. PubMed ID: 10515375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
    El-Sawy T; Belperio JA; Strieter RM; Remick DG; Fairchild RL
    Circulation; 2005 Jul; 112(3):320-31. PubMed ID: 15998678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
    Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
    Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H; Grusby MJ; Khoury SJ; Sayegh MH
    J Clin Invest; 2000 Jul; 106(1):63-72. PubMed ID: 10880049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
    Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
    Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of corneal allograft reaction by CTLA4-Ig.
    Hoffmann F; Zhang EP; Pohl T; Kunzendorf U; Wachtlin J; Bulfone-Paus S
    Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):535-40. PubMed ID: 9285225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costimulation blockade of CD40 and CD28 pathways in limb transplantation.
    Tung TH; Mackinnon SE; Mohanakumar T
    Transplant Proc; 2008 Dec; 40(10):3723-4. PubMed ID: 19100474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gene transfer CTLA4Ig and anti-CD40L monoclonal antibody on islet xenograft rejection in mice.
    Zhang J; Li H; Jiang N; Zhang Q; Wang GS; Yi HM; Fu BS; Wang GY; Yang Y; Chen GH
    Transplant Proc; 2010 Jun; 42(5):1835-7. PubMed ID: 20620534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival.
    Llaudo I; Fribourg M; Medof ME; Conde P; Ochando J; Heeger PS
    Am J Transplant; 2019 Mar; 19(3):633-645. PubMed ID: 30106232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
    Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.